NS
CORT icon

NBC Securities’s Corcept Therapeutics CORT Stock Holding History

NBC Securities’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,202
Closed -$266K – 2822
2025
Q3 		$266K Buy
3,202
+846
+36% +$61.2K 0.02% 732
2025
Q2 		$172K Buy
2,356
+2,174
+1,195% +$158K 0.01% 884
2025
Q1 		$20K Buy
+182
New +$11.1K ﹤0.01% 1479
2024
Q4 		– Sell
-255
Closed -$11K – 1419
2024
Q3 		$11K Sell
255
-415
-62% -$14.7K ﹤0.01% 1691
2024
Q2 		$21K Buy
670
+255
+61% +$6.99K ﹤0.01% 1437
2024
Q1 		$11K Hold
415
– – ﹤0.01% 1659
2023
Q4 		$13K Sell
415
-200
-33% -$5.49K ﹤0.01% 1611
2023
Q3 		$16K Buy
+615
New +$17.8K ﹤0.01% 1541

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NBC Securities's CORT Position: Q4 2025 in Review

NBC Securities sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 3,202 shares — an estimated $266K sold.

NBC Securities first reported a position in CORT in Q3 2023 and held it in 8 quarters. The position peaked at $266K in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • NBC Securities reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 3,202 Corcept Therapeutics shares in Q4 2025, an estimated $266K.
  • NBC Securities first reported a position in Corcept Therapeutics in Q3 2023 and held it in 8 quarters.
  • NBC Securities's Corcept Therapeutics position peaked at $266K in Q3 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.